Do We Need to Measure Drug Levels of NOACs?

Dr. Goldhaber interviews Dr. Ruff on data from RE-LY showing that stroke and bleeding outcomes correlate with dabigatran plasma concentrations.

Source: Medscape Pharmacists Podcast - May 5, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts